首页> 外文期刊>Diseases of Aquatic Organisms >Immunogenicity of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells
【24h】

Immunogenicity of a recombinant infectious hematopoietic necrosis virus glycoprotein produced in insect cells

机译:昆虫细胞中产生的重组感染性造血坏死病毒糖蛋白的免疫原性

获取原文
           

摘要

ABSTRACT: A recombinant infectious hematopoietic necrosis virus (IHNV) glycoprotein (G protein), produced in Spodoptera frugiperda (Sf9) cells following infection with a baculovirus vector containing the full-length (1.6 kb) glycoprotein gene, provided very limited protection in rainbow trout Oncorhynchus mykiss challenged with IHNV. Fish were injected intraperitoneally (i.p.) with Sf9 cells grown at 20°C (RecGlow) or 27°C (RecGhigh) expressing the glycoprotein gene. Various antigen (Ag) preparations were administered to adult rainbow trout or rainbow trout fry. Sera collected from adult fish were evaluated for IHNV neutralization activity by a complement-dependent neutralization assay. Anti-IHNV neutralizing activity was observed in sera, but the percent of fish responding was significantly lower (p 0.05) in comparison to fish immunized with a low virulence strain of IHNV (LV-IHNV). A small number of fish immunized with RecGlow or RecGhigh possessed IHNV G protein specific antibodies (Abs) in their serum. Cumulative mortality (CM) of rainbow trout fry (mean weight, 1 g) vaccinated by i.p. injection of freeze/thawed Sf9 cells producing RecGlow was 18% in initial trials following IHNV challenge. This level of protection was significant (p 0.05) but was not long lasting, and neutralizing Abs were not detected in pooled serum samples. When trout fry (mean weight, 0.6 g) were vaccinated with supernatant collected from sonicated Sf9 cells, Sf9 cells producing RecGlow, or Sf9 cells producing RecGhigh, CM averaged 46%. Protection was enhanced over negative controls, but not the positive controls (2% CM), suggesting that in the first trial soluble cellular proteins may have provided some level of non-specific protection, regardless of recombinant protein expression. Although some immunity was elicited in fish, and RecGlow provided short-term protection from IHNV, Ab-mediated protection could not be demonstrated. The results suggest that recombinant G proteins produced in insect cells lack the immunogenicity associated with vaccination of fish with an attenuated strain of IHNV.>
机译:摘要:重组感染性造血坏死病毒(IHNV)糖蛋白(G蛋白),由含有全长的杆状病毒载体感染后在 Spodoptera frugiperda (Sf9)细胞中产生(1.6 kb)糖蛋白基因在受IHNV攻击的虹鳟钩端螺旋体 mykiss 中提供的保护非常有限。向鱼腹膜内(腹膜内)注射表达糖蛋白基因的Sf9细胞,该细胞在20°C(RecG low )或27°C(RecG high )生长。将各种抗原(Ag)制剂施用于成年虹鳟鱼或虹鳟鱼苗。通过补体依赖性中和测定评估从成年鱼收集的血清的IHNV中和活性。在血清中观察到抗IHNV中和活性,但与用低毒力IHNV株(LV-IHNV)免疫的鱼相比,鱼的应答百分比显着降低(p <0.05)。少量用RecG low 或RecG sub 免疫的鱼的血清中含有IHNV G蛋白特异性抗体(Abs)。 i.p.疫苗接种的虹鳟鱼苗(平均重量,1 g)的累积死亡率(CM)。在IHNV攻击后的初始试验中,产生RecG low 的冷冻/解冻Sf9细胞的注射率为18%。此保护水平显着(p <0.05),但并不持久,在合并的血清样本中未检测到中和抗体。用从超声处理的Sf9细胞,产生RecG low 的Sf9细胞或产生RecG high 的Sf9细胞收集的上清液接种鳟鱼苗(平均体重0.6 g)时,CM平均为46 %。与阴性对照相比,保护作用得到了增强,但与阳性对照(2%CM)相比却得到了增强,这表明在第一个试验中,可溶性细胞蛋白可能提供了一定水平的非特异性保护,而与重组蛋白表达无关。尽管在鱼类中引起了一定的免疫力,并且RecG low 提供了针对IHNV的短期保护,但无法证明Ab介导的保护。结果表明,昆虫细胞中产生的重组G蛋白缺乏与IHNV减毒株疫苗接种有关的免疫原性。>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号